From: A meta-analysis of the performance of the PimaTM CD4 for point of care testing
 | Overall group | Venous | Capillary |
---|---|---|---|
 | n = 11,803 | n = 7,648 | n = 4155 |
Reference technology | Â | Â | Â |
Mean (absolute range) | 428 (402–453) | 436 (418–474) | 411 (384–437) |
Median (IQR) | 383 (249–555) | 390 (254–565) | 371 (241–537) |
Pima | Â | Â | Â |
Mean (absolute range) | 404 (373–425) | 416 (388–444) | 382 (351–412) |
Median (IQR) | 363 (234–524) | 373 (242–534) | 342 (221–507) |
Agreement | Â | Â | Â |
Accuracy and Precision (cells/ul) | Â | Â | Â |
Mean bias (Pima - Reference) | −23 | −23 | −24 |
Mean bias (CI) | (−22;-25) | (−21; −25) | (−20; −28) |
SD bias | 106 | 93 | 126 |
Percentage similarity mean % | 101 | 100 | 103 |
Percentage similarity SD % | 87 | 67 | 116 |
Percentage similarity CV % | 86 | 67 | 113 |
Percent bias (SD) >100 cells/μl | n = 11037, −3.26 % (26.4) | n = 7190, −3.1 % (22.5) | n = 3487, −3.54 % (32.3) |
Concordance correlation (Pc) | 0.914 (0.911, 0.917) | 0.934 (0.931, 0.937) | 0.874 (0.867, 0.881) |
Strength of agreement | moderate | moderate | poor |
Overall cell variance | Â | Â | Â |
<100 cells/ula | Â | 34 | 73 |
100-350 cesll/ulb | Â | 38 | 51 |
350-500 cells/ulb | Â | 33 | 57 |
>500 cells/ulb | Â | 53 | 79 |
Percentage bias across all rangesc | Â | 10Â % | 15Â % |